App-Quantinova.ai

Low Agreement of 18F-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) and Cardiac Magnetic Resonance (CMR) in Patients With Conduction Disease Due to Cardiac Sarcoidosis

David Birnie - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cardiac sarcoidosis

N/A

Young Women Post-MI Have Higher Levels of Inflammation Before and After Stress Testing

Amit J Shah - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Interleukin

Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial

Sithu Win - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

Irbesartan

Early Increases in Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin, Taxanes, and Trastuzumab

Bonnie Ky - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cardiotoxicity

Trastuzumab

Autonomic Effects of Acute Psychological Stress Are Greater in Young Women Than Men After Myocardial Infarction

Pratik M Pimple - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Randomized Trial of a Virtua- Cardiac Rehabilitation Program Delivered at a Distance via the Internet

Scott A Lear - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

Anatomical Risk Factors Associated With Left-Sided Pulmonary Vein Obstruction in Single Ventricle Patients

Jiaquan Zhu - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Postoperative Outcome in Primary Mitral Regurgitation: Impact of Preoperative Exercise Pulmonary Hypertension

Erwan Donal - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pulmonary arterial hypertension

N/A

Outcomes of Acute Heart Failure (AHF) in Different Clinical Settings After Emergency Department (ED) Separation: Risk Stratification With the Emergency Heart Failure Mortality Risk Grade (EHMRG)

Limei Zhou - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Hydroxyzine

Cyclosporine-a Mediated Impairment of Human Coronary Artery Smooth Muscle Cell Phospho-nrf2 and Vascular Injury Function Are Rescued by Tert-Butylhydroquinone

Mitesh V Badiwala - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

Nitroprusside sodium

Genetic Risk Factors Associated With Development of Paroxysmal versus Non-Paroxysmal Atrial Fibrillation

Daniel Chasman - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Use of a Genetic Risk Score to Predict Adverse Outcomes After ACS

James C. Engert - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Grace

Stent Thrombosis and Major Bleeding With Bivalirudin versus Active Control in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Behnood Bikdeli - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Determinants of Vt Occurrence in Patients With Nonischemic and Dilated Cardiomyopathy: Insights From the Study of Explanted Human Hearts

Nirmal Parajuli - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Magnetic Resonance Imaging-Detected Carotid Plaque Characteristics Predict Systemic Cardiovascular Outcomes in Patients With Clinically Established Atherosclerosis in the AIH-HIGH Study

Xue-Qiao Zhao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

N/A

Sustained LDL-C Lowering and Stable Hepatic Fat Levels in Patients With Homozygous Familial Hypercholesterolemia Treated With the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide: Results of an Ongoing Long-Term Extension Study

Dirk J Blom - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypercholesterolemia, Familial, 1

Biaxin

Genetic Deficiency of the Hydrogen Sulfide H2S Enzyme, Cystathionine Gamma-lyase (CSE) Results in eNOS Uncoupling and Exacerbated Myocardial Injury: Evidence for Cross Talk Between NO and H2S Signaling

Shashi Bushan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

Sapropterin

Abnormal Peripheral Muscle Oxygenation During Submaximal Exercise Contributes to Exercise Intolerance in Pulmonary Arterial Hypertension

Francois Potus - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Inhibition of Four-and-a-Half LIM Domain Protein-2 Attenuates Atherogenesis in ApoE-/- Mice: Role of Immune T-Cells

Maryam Heidari - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary Artery Disease

ICAM-1

Outcomes After In-Utero Cardiac Interventions: A Preliminary Report of the Collaborative International Fetal Cardiac Intervention Registry

Michael Belfort - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Filters

28841 Abstracts